The Oncosearch | Oncotarget

Non-coding RNAs as emerging regulators of epithelial to mesenchymal transition in non-small cell lung cancer Review

Ying Chen, Lu Lu, Bing Feng, Siqi Han, Shiyun Cui, Xiaoyuan Chu, Longbang Chen, Rui Wang

Published Mar 18, 2017 · Vol. 8, No. 22 · pp. 36787-36799

GD2 expression in breast cancer Research Paper

Giulia Orsi, Monica Barbolini, Guido Ficarra, Giovanni Tazzioli, Paola Manni, Tiziana Petrachi, Ilenia Mastrolia, Enrico Orvieto, Carlotta Spano, Malvina Prapa, Shaniko Kaleci, Roberto Dâ€™Amico, Valentina Guarneri, Maria Vittoria Dieci, Stefano Cascinu, Pierfranco Conte, Federico Piacentini, Massimo Dominici

Published Mar 18, 2017 · Vol. 8, No. 19 · pp. 31592-31600

Erythropoietin drives breast cancer progression by activation of its receptor EPOR Research Paper

Ka Kui Chan, Kyle B. Matchett, Jonathan A. Coulter, Hiu-Fung Yuen, Cian M. McCrudden, Shu-Dong Zhang, Gareth W. Irwin, Matthew A. Davidson, Thomas RÃ¼licke, Sophie Schober, Ludger Hengst, Heidelinde Jaekel, Angela Platt-Higgins, Philip S. Rudland, Ken I. Mills, Perry Maxwell, Mohamed El-Tanani, Terence R. Lappin

Published Mar 18, 2017 · Vol. 8, No. 24 · pp. 38251-38263

Camptothecin resistance is determined by the regulation of topoisomerase I degradation mediated by ubiquitin proteasome pathway Research Paper

Koji Ando, Ankur K. Shah, Vibhu Sachdev, Benjamin P. Kleinstiver, Julian Taylor-Parker, Moira M. Welch, Yiheng Hu, Ravi Salgia, Forest M. White, Jeffrey D. Parvin, Al Ozonoff, Lucia E. Rameh, J. Keith Joung, Ajit K. Bharti

Published Mar 18, 2017 · Vol. 8, No. 27 · pp. 43733-43751

Development of [¹¹C]vemurafenib employing a carbon-11 carbonylative Stille coupling and preliminary evaluation in mice bearing melanoma tumor xenografts Research Paper

Paul Slobbe, Albert D. Windhorst, Kevin Adamzek, Marije Bolijn, Robert C. Schuit, DaniÃ«lle A.M. Heideman, Guus A.M.S. van Dongen, Alex J. Poot

Published Mar 17, 2017 · Vol. 8, No. 24 · pp. 38337-38350

Glutaminase inhibitor CB-839 synergizes with carfilzomib in resistant multiple myeloma cells Research Paper

Ravyn M. Thompson, Dominik Dytfeld, Leticia Reyes, Reeder M. Robinson, Brittany Smith, Yefim Manevich, Andrzej Jakubowiak, Mieczyslaw Komarnicki, Anna Przybylowicz-Chalecka, Tomasz Szczepaniak, Amit K. Mitra, Brian G. Van Ness, Magdalena Luczak, Nathan G. Dolloff

Published Mar 16, 2017 · Vol. 8, No. 22 · pp. 35863-35876

Niclosamide is a potential therapeutic for familial adenomatosis polyposis by disrupting Axin-GSK3 interaction Research Paper

Sung Yong Ahn, Nam Hee Kim, Kyungro Lee, Yong Hoon Cha, Ji Hye Yang, So Young Cha, Eunae Sandra Cho, Yoonmi Lee, Jeong Seok Cha, Hyun Soo Cho, Yoon Jeon, Young-Su Yuk, Suebean Cho, Kyoung Tai No, Hyun Sil Kim, Ho Lee, Jiwon Choi, Jong In Yook

Published Mar 16, 2017 · Vol. 8, No. 19 · pp. 31842-31855

Clinical framework for next generation sequencing based analysis of treatment predictive mutations and multiplexed gene fusion detection in non-small cell lung cancer Research Paper

Kajsa Ericson Lindquist, Anna Karlsson, Per LevÃ©en, Hans BrunnstrÃ¶m, Christel ReuterswÃ¤rd, Karolina Holm, Mats JÃ¶nsson, Karin Annersten, Frida Rosengren, Karin JirstrÃ¶m, Jaroslaw Kosieradzki, Lars Ek, Ã…ke Borg, Maria Planck, GÃ¶ran JÃ¶nsson, Johan Staaf

Published Mar 16, 2017 · Vol. 8, No. 21 · pp. 34796-34810

An absence of platelet activation following thalidomide treatment in vitro or in vivo Research Paper

Jianlin Qiao, Yulu Wu, Xiaoqing Wu, Yun Liu, Xiaoqian Li, Wen Ju, Kunming Qi, Depeng Li, Elizabeth E. Gardiner, Robert K. Andrews, Lingyu Zeng, Kailin Xu

Published Mar 15, 2017 · Vol. 8, No. 22 · pp. 35776-35782

Preclinical development of G1T38: A novel, potent and selective inhibitor of cyclin dependent kinases 4/6 for use as an oral antineoplastic in patients with CDK4/6 sensitive tumors Research Paper

John E. Bisi, Jessica A. Sorrentino, Jamie L. Jordan, David D. Darr, Patrick J. Roberts, Francis X. Tavares, Jay C. Strum

Published Mar 15, 2017 · Vol. 8, No. 26 · pp. 42343-42358

Auranofin radiosensitizes tumor cells through targeting thioredoxin reductase and resulting overproduction of reactive oxygen species Research Paper

Hui Wang, Soumaya Bouzakoura, Sven de Mey, Heng Jiang, Kalun Law, InÃ¨s Dufait, Cyril Corbet, Valeri Verovski, Thierry Gevaert, Olivier Feron, Dirk Van den Berge, Guy Storme, Mark De Ridder

Published Mar 10, 2017 · Vol. 8, No. 22 · pp. 35728-35742

Model-based unsupervised learning informs metformin-induced cell-migration inhibition through an AMPK-independent mechanism in breast cancer Research Paper

Arjun P. Athreya, Krishna R. Kalari, Junmei Cairns, Alan J. Gaglio, Quin F. Wills, Nifang Niu, Richard Weinshilboum, Ravishankar K. Iyer, Liewei Wang

Published Mar 10, 2017 · Vol. 8, No. 16 · pp. 27199-27215

Targeting the centriolar replication factor STIL synergizes with DNA damaging agents for treatment of ovarian cancer Research Paper

Noa Rabinowicz, Lingegowda S. Mangala, Kevin R. Brown, Cintia Checa-Rodriguez, Asher Castiel, Oren Moskovich, Giulia Zarfati, Luba Trakhtenbrot, Adva Levy-Barda, Dahai Jiang, Cristian Rodriguez-Aguayo, Sunila Pradeep, Yael van Praag, Gabriel Lopez-Berestein, Ahuvit David, Ilya Novikov, Pablo Huertas, Robert Rottapel, Anil K. Sood, Shai Izraeli

Published Mar 10, 2017 · Vol. 8, No. 16 · pp. 27380-27392

Integrated analysis of promoter methylation and expression of telomere related genes in breast cancer Research Paper

Jianfu Heng, Fan Zhang, Xinwu Guo, Lili Tang, Limin Peng, Xipeng Luo, Xunxun Xu, Shouman Wang, Lizhong Dai, Jun Wang

Published Mar 9, 2017 · Vol. 8, No. 15 · pp. 25442-25454

Experience with precision genomics and tumor board, indicates frequent target identification, but barriers to delivery Research Paper

Alan H. Bryce, Jan B. Egan, Mitesh J. Borad, A. Keith Stewart, Grzegorz S. Nowakowski, Asher Chanan-Khan, Mrinal M. Patnaik, Stephen M. Ansell, Michaela S. Banck, Steven I. Robinson, Aaron S. Mansfield, Eric W. Klee, Gavin R. Oliver, Jennifer B. McCormick, Norine E. Huneke, Colleen M. Tagtow, Robert B. Jenkins, Kandelaria M. Rumilla, Sarah E. Kerr, Jean-Pierre A. Kocher, Scott A. Beck, Martin E. Fernandez-Zapico, Gianrico Farrugia, Konstantinos N. Lazaridis, Robert R. McWilliams

Published Mar 9, 2017 · Vol. 8, No. 16 · pp. 27145-27154

Targeting CD157 in AML using a novel, Fc-engineered antibody construct Research Paper

Christina Krupka, Felix S. Lichtenegger, Thomas KÃ¶hnke, Jan BÃ¶geholz, Veit BÃ¼cklein, Michael Roiss, Torben Altmann, To Uyen Do, Rachel Dusek, Keith Wilson, Arnima Bisht, Jon Terrett, Dee Aud, Esteban Pombo-Villar, Christian Rohlff, Wolfgang Hiddemann, Marion Subklewe

Published Mar 9, 2017 · Vol. 8, No. 22 · pp. 35707-35717

Identifying the structure-activity relationship of leelamine necessary for inhibiting intracellular cholesterol transport Research Paper

Raghavendra Gowda, Gajanan S. Inamdar, Omer Kuzu, Saketh S. Dinavahi, Jacek Krzeminski, Madhu Babu Battu, Sreedhara R. Voleti, Shantu Amin, Gavin P. Robertson

Published Mar 8, 2017 · Vol. 8, No. 17 · pp. 28260-28277

A feasibility study of returning clinically actionable somatic genomic alterations identified in a research laboratory Priority Research Paper

Natalia Paez Arango, Lauren Brusco, Kenna R. Mills Shaw, Ken Chen, Agda Karina Eterovic, Vijaykumar Holla, Amber Johnson, Beate Litzenburger, Yekaterina B. Khotskaya, Nora Sanchez, Ann Bailey, Xiaofeng Zheng, Chacha Horombe, Scott Kopetz, Carol J. Farhangfar, Mark Routbort, Russell Broaddus, Elmer V. Bernstam, John Mendelsohn, Gordon B. Mills, Funda Meric-Bernstam

Published Mar 8, 2017 · Vol. 8, No. 26 · pp. 41806-41814

Targeting HOX/PBX dimers in cancer Review

Richard Morgan, Mohamed El-Tanani, Keith D. Hunter, Kevin J. Harrington, Hardev S. Pandha

Published Mar 7, 2017 · Vol. 8, No. 19 · pp. 32322-32331

Disulfide bond disrupting agents activate the unfolded protein response in EGFR- and HER2-positive breast tumor cells Research Paper

Renan B. Ferreira, Mengxiong Wang, Mary E. Law, Bradley J. Davis, Ashton N. Bartley, Paul J. Higgins, Michael S. Kilberg, Katherine E. Santostefano, Naohiro Terada, Coy D. Heldermon, Ronald K. Castellano, Brian K. Law

Published Mar 7, 2017 · Vol. 8, No. 17 · pp. 28971-28989

Publication Alerts

European Cancer and Oncology Congress

Post-Publication Promotion

Search Oncotarget

Non-coding RNAs as emerging regulators of epithelial to mesenchymal transition in non-small cell lung cancer Review

GD2 expression in breast cancer Research Paper

Erythropoietin drives breast cancer progression by activation of its receptor EPOR Research Paper

Camptothecin resistance is determined by the regulation of topoisomerase I degradation mediated by ubiquitin proteasome pathway Research Paper

Development of [¹¹C]vemurafenib employing a carbon-11 carbonylative Stille coupling and preliminary evaluation in mice bearing melanoma tumor xenografts Research Paper

Glutaminase inhibitor CB-839 synergizes with carfilzomib in resistant multiple myeloma cells Research Paper

Niclosamide is a potential therapeutic for familial adenomatosis polyposis by disrupting Axin-GSK3 interaction Research Paper

Clinical framework for next generation sequencing based analysis of treatment predictive mutations and multiplexed gene fusion detection in non-small cell lung cancer Research Paper

An absence of platelet activation following thalidomide treatment in vitro or in vivo Research Paper

Preclinical development of G1T38: A novel, potent and selective inhibitor of cyclin dependent kinases 4/6 for use as an oral antineoplastic in patients with CDK4/6 sensitive tumors Research Paper

Auranofin radiosensitizes tumor cells through targeting thioredoxin reductase and resulting overproduction of reactive oxygen species Research Paper

Model-based unsupervised learning informs metformin-induced cell-migration inhibition through an AMPK-independent mechanism in breast cancer Research Paper

Targeting the centriolar replication factor STIL synergizes with DNA damaging agents for treatment of ovarian cancer Research Paper

Integrated analysis of promoter methylation and expression of telomere related genes in breast cancer Research Paper

Experience with precision genomics and tumor board, indicates frequent target identification, but barriers to delivery Research Paper

Targeting CD157 in AML using a novel, Fc-engineered antibody construct Research Paper

Identifying the structure-activity relationship of leelamine necessary for inhibiting intracellular cholesterol transport Research Paper

A feasibility study of returning clinically actionable somatic genomic alterations identified in a research laboratory Priority Research Paper

Targeting HOX/PBX dimers in cancer Review

Disulfide bond disrupting agents activate the unfolded protein response in EGFR- and HER2-positive breast tumor cells Research Paper

Publication Alerts

European Cancer and Oncology Congress

Oncoscience

Post-Publication Promotion

Search Oncotarget

Non-coding RNAs as emerging regulators of epithelial to mesenchymal transition in non-small cell lung cancer Review

GD2 expression in breast cancer Research Paper

Erythropoietin drives breast cancer progression by activation of its receptor EPOR Research Paper

Camptothecin resistance is determined by the regulation of topoisomerase I degradation mediated by ubiquitin proteasome pathway Research Paper

Development of [11C]vemurafenib employing a carbon-11 carbonylative Stille coupling and preliminary evaluation in mice bearing melanoma tumor xenografts Research Paper

Glutaminase inhibitor CB-839 synergizes with carfilzomib in resistant multiple myeloma cells Research Paper

Niclosamide is a potential therapeutic for familial adenomatosis polyposis by disrupting Axin-GSK3 interaction Research Paper

Clinical framework for next generation sequencing based analysis of treatment predictive mutations and multiplexed gene fusion detection in non-small cell lung cancer Research Paper

An absence of platelet activation following thalidomide treatment in vitro or in vivo Research Paper

Preclinical development of G1T38: A novel, potent and selective inhibitor of cyclin dependent kinases 4/6 for use as an oral antineoplastic in patients with CDK4/6 sensitive tumors Research Paper

Auranofin radiosensitizes tumor cells through targeting thioredoxin reductase and resulting overproduction of reactive oxygen species Research Paper

Model-based unsupervised learning informs metformin-induced cell-migration inhibition through an AMPK-independent mechanism in breast cancer Research Paper

Targeting the centriolar replication factor STIL synergizes with DNA damaging agents for treatment of ovarian cancer Research Paper

Integrated analysis of promoter methylation and expression of telomere related genes in breast cancer Research Paper

Experience with precision genomics and tumor board, indicates frequent target identification, but barriers to delivery Research Paper

Targeting CD157 in AML using a novel, Fc-engineered antibody construct Research Paper

Identifying the structure-activity relationship of leelamine necessary for inhibiting intracellular cholesterol transport Research Paper

A feasibility study of returning clinically actionable somatic genomic alterations identified in a research laboratory Priority Research Paper

Targeting HOX/PBX dimers in cancer Review

Disulfide bond disrupting agents activate the unfolded protein response in EGFR- and HER2-positive breast tumor cells Research Paper

Development of [¹¹C]vemurafenib employing a carbon-11 carbonylative Stille coupling and preliminary evaluation in mice bearing melanoma tumor xenografts Research Paper